SOPHiA GENETICS Reports Fourth Quarter and Full Year 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Needham Starts NeoVolta (NEOV) at Buy
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
SOPHiA GENETICS SA (SOPH) Misses Q4 EPS by 15c, Misses on Revenue; Offers FY24 Revenue Guidance
March 5, 2024 6:48 AM ESTSOPHiA GENETICS SA (NASDAQ: SOPH) reported Q4 EPS of ($0.37), $0.15 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $17 million versus the consensus estimate of $17.33 million.
GUIDANCE:
SOPHiA GENETICS SA sees FY2024 revenue of $78-81 million, versus the... More
